The Flowers of War: Ukraine Smith Turns Guns, Ammo into Art

Viktor Mikhalev works in a workshop in his house in Donetsk, Russian-controlled Donetsk region, eastern Ukraine, Saturday, March 4, 2023. (AP)
Viktor Mikhalev works in a workshop in his house in Donetsk, Russian-controlled Donetsk region, eastern Ukraine, Saturday, March 4, 2023. (AP)
TT

The Flowers of War: Ukraine Smith Turns Guns, Ammo into Art

Viktor Mikhalev works in a workshop in his house in Donetsk, Russian-controlled Donetsk region, eastern Ukraine, Saturday, March 4, 2023. (AP)
Viktor Mikhalev works in a workshop in his house in Donetsk, Russian-controlled Donetsk region, eastern Ukraine, Saturday, March 4, 2023. (AP)

A blacksmith in the Russian-controlled eastern Ukrainian city of Donetsk is practically beating swords into ploughshares, and turning one man’s trash into treasures. Viktor Mikhalev takes weapons and ammunition and produces what he calls the flowers of war.

Mikhalev, who trained as a welder, lives and works in a house whose fence and door are decorated with forged flowers and grapes. In his workshop are piles of half-burnt machine guns and shells from the war’s front line. Friends and acquaintances bring them as raw material for his art.

Donetsk, the center of Ukraine’s industrial heartland of the Donbas, has been engulfed by fighting ever since the Moscow-backed separatist rebellion erupted in April 2014, weeks after Russia’s illegal annexation of Ukraine’s Crimean Peninsula.

The Kremlin has made capturing the entire region a key goal of its invasion that began a year ago, and it illegally annexed Donetsk along with three other regions in eastern and southern Ukraine in September, declaring them part of Russia.

Fierce fighting has focused on the city of Bakhmut in the Donetsk region, and the city of Donetsk itself also has been frequently hit by shelling.

The smell of iron and paint permeates Mikhalev’s workshop, also decorated from floor to ceiling with dozens of religious icons. He makes the art as a keepsake, a souvenir of the war in eastern Ukraine.

“Real flowers will not last long, and my roses will become a reminder for a long memory,” the blacksmith says.

He began the project when a friend brought him broken machine guns. A month later, he exhibited his war art in a Donetsk museum. Since then, he’s constantly been making what he calls “flowers of war.” In addition, he constructs stands for writing pens from parts of a grenade launcher and a cartridge case.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”